When and Where It's Happening
In the backdrop of a widespread shortage of weight-loss drugs and rising demand, pharmaceutical giant Novo Nordisk is taking significant steps in the United States to restrict compounded versions of its well-known weight-loss drugs, Ozempic and Wegovy. The Danish compa...

Read More...